You are here: Industry Insights > breast cancer drug

News List

UK’s NICE backs Novartis breast cancer drug Kisqali pharmaceutical-technology
July 22, 2019
The UK’s National Institute for Health and Care Excellence (NICE) has approved Novartis’ drug Kisqali (ribociclib) in combination with fulvestrant for the treatment of certain patients with advanced breast cancer.
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response biospectrumasia
May 09, 2019
Pivotal phase 2 DESTINY-Breast01 trial met primary endpoint, supporting global regulatory submission plan to start in first half of fiscal year 2019
Troubled Immunomedics now hit with CRL for breast cancer drug candidate fiercepharma
January 21, 2019
The troubles for troubled Immunomedics keep piling up. The New Jersey-based biotech, which has gone through a failed tie-up deal, boardroom cleansing and FDA Form 483 issues, today reported it has received a complete response letter from the FDA related t
Troubled Immunomedics now hit with CRL for breast cancer drug candidate fiercepharma
January 21, 2019
The troubles for troubled Immunomedics keep piling up. The New Jersey-based biotech, which has gone through a failed tie-up deal, boardroom cleansing and FDA Form 483 issues, today reported it has received a complete response letter from the FDA related t
Experimental breast cancer drug could help patients with leukemia, too fiercebiotech
July 26, 2018
For the first time, researchers have discovered a link between a pathway that activates a protein called heat shock transcription factor 1 (HSF1) and leukemia......